ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 237 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.58 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $101,187,000 | +59.5% | 1,088,735 | +2.2% | 0.01% | +33.3% |
| Q3 2021 | $63,434,000 | -13.4% | 1,065,226 | -0.9% | 0.01% | -10.0% |
| Q2 2021 | $73,274,000 | +3.3% | 1,074,410 | +5.1% | 0.01% | -9.1% |
| Q1 2021 | $70,925,000 | +0.3% | 1,022,134 | +11.1% | 0.01% | -8.3% |
| Q4 2020 | $70,686,000 | +9.2% | 920,037 | +6.3% | 0.01% | -7.7% |
| Q3 2020 | $64,703,000 | +19.2% | 865,133 | +0.3% | 0.01% | +8.3% |
| Q2 2020 | $54,292,000 | +73.3% | 862,476 | +15.6% | 0.01% | +50.0% |
| Q1 2020 | $31,323,000 | -50.7% | 745,805 | -46.7% | 0.01% | +14.3% |
| Q4 2019 | $63,558,000 | +105.6% | 1,399,362 | +107.2% | 0.01% | 0.0% |
| Q3 2019 | $30,910,000 | -20.8% | 675,352 | +1.5% | 0.01% | -22.2% |
| Q2 2019 | $39,013,000 | +43.0% | 665,424 | +9.4% | 0.01% | +28.6% |
| Q1 2019 | $27,276,000 | -38.1% | 608,453 | -46.2% | 0.01% | 0.0% |
| Q4 2018 | $44,036,000 | +82.9% | 1,130,578 | +116.1% | 0.01% | 0.0% |
| Q3 2018 | $24,078,000 | +9.9% | 523,219 | +4.1% | 0.01% | 0.0% |
| Q2 2018 | $21,915,000 | +24.7% | 502,640 | +12.9% | 0.01% | +16.7% |
| Q1 2018 | $17,581,000 | +47.4% | 445,099 | +26.7% | 0.01% | +50.0% |
| Q4 2017 | $11,929,000 | +38.0% | 351,181 | +3.6% | 0.00% | +33.3% |
| Q3 2017 | $8,644,000 | +97.9% | 338,995 | +31.0% | 0.00% | +50.0% |
| Q2 2017 | $4,367,000 | – | 258,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| IFP Advisors, Inc | 2 | $1,000 | 0.00% |